Oh SH*T, it's starting, Putin launching massive offensive | Redacted with Clayton Morris
On Today's Show:
- 0:00 Countdown
- 31:37 Welcome
- 36:41 Putin's Invasion Force
- 1:05:48 Nordstream Discovery
- 1:26:54 Muslims Protest Trudeau
- 1:42:59 Big Pharma
FDA approves new drug to protect babies from RSV.
Outside advisers to the federal government have previously hailed nirsevimab's showing in clinical trials as potentially "groundbreaking" for protecting babies. A panel of the FDA's outside experts voted in June to back the drug's safety and efficacy.
"Today's approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system," the FDA's Dr. John Farley, director of the Office of Infectious Diseases in the FDA's Center for Drug Evaluation and Research, said in a statement.
Drugmakers AstraZeneca and Sanofi, which will market nirsevimab under the brand name Beyfortus, have touted results showing an 83.2% reduction in hospitalizations from RSV infections after infants got their antibody injection.
"Today's approval marks an unprecedented moment for protecting infant health in the U.S., following an RSV season that took a record toll on infants, their families, and the U.S. healthcare system," Sanofi executive vice president Thomas Triomphe said in a statement.
Comments
Post a Comment